Chromodomain-helicase-DNA-binding protein 7 is an ATP-dependent 'chromatin' or 'nucleosome' remodeling factor [5] that in humans is encoded by the CHD7gene.[6][7]
Delahaye A, Sznajer Y, Lyonnet S, Elmaleh-Bergès M, Delpierre I, Audollent S, etal. (August 2007). "Familial CHARGE syndrome because of CHD7 mutation: clinical intra- and interfamilial variability". Clinical Genetics. 72 (2): 112–121. doi:10.1111/j.1399-0004.2007.00821.x. PMID17661815. S2CID8143298.
Van de Laar I, Dooijes D, Hoefsloot L, Simon M, Hoogeboom J, Devriendt K (November 2007). "Limb anomalies in patients with CHARGE syndrome: an expansion of the phenotype". American Journal of Medical Genetics. Part A. 143A (22): 2712–2715. doi:10.1002/ajmg.a.32008. PMID17937444. S2CID21353716.
Holak HM, Kohlhase J, Holak SA, Holak NH (June 2008). "New recognized ophthalmic morphologic anomalies in CHARGE syndrome caused by the R2319C mutation in the CHD7 gene". Ophthalmic Genetics. 29 (2): 79–84. doi:10.1080/13816810801918391. PMID18484313. S2CID205807551.
Wincent J, Schulze A, Schoumans J (2009). "Detection of CHD7 deletions by MLPA in CHARGE syndrome patients with a less typical phenotype". European Journal of Medical Genetics. 52 (4): 271–272. doi:10.1016/j.ejmg.2009.02.005. PMID19248844.
Wincent J, Holmberg E, Strömland K, Soller M, Mirzaei L, Djureinovic T, etal. (July 2008). "CHD7 mutation spectrum in 28 Swedish patients diagnosed with CHARGE syndrome". Clinical Genetics. 74 (1): 31–38. doi:10.1111/j.1399-0004.2008.01014.x. PMID18445044. S2CID205406725.
Jongmans MC, Hoefsloot LH, van der Donk KP, Admiraal RJ, Magee A, van de Laar I, etal. (January 2008). "Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability". American Journal of Medical Genetics. Part A. 146A (1): 43–50. doi:10.1002/ajmg.a.31921. PMID18074359. S2CID24479591.
Vuorela PE, Penttinen MT, Hietala MH, Laine JO, Huoponen KA, Kääriäinen HA (October 2008). "A familial CHARGE syndrome with a CHD7 nonsense mutation and new clinical features". Clinical Dysmorphology. 17 (4): 249–253. doi:10.1097/MCD.0b013e328306a704. PMID18978652. S2CID35257043.
Bergman JE, de Wijs I, Jongmans MC, Admiraal RJ, Hoefsloot LH, van Ravenswaaij-Arts CM (2008). "Exon copy number alterations of the CHD7 gene are not a major cause of CHARGE and CHARGE-like syndrome". European Journal of Medical Genetics. 51 (5): 417–425. doi:10.1016/j.ejmg.2008.03.003. PMID18472328.
Lee YW, Kim SC, Shin YL, Kim JW, Hong HS, Lee YK, etal. (March 2009). "Clinical and genetic analysis of the CHD7 gene in Korean patients with CHARGE syndrome". Clinical Genetics. 75 (3): 290–293. doi:10.1111/j.1399-0004.2008.01127.x. PMID19159393. S2CID43480931.
Qi Q, Yi L, Yang C, Chen H, Shen L, Mo X, etal. (December 2008). "[Mutation analysis of the CHD7 gene in patients with congenital heart disease]". Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics. 25 (6): 637–641. PMID19065520.
Writzl K, Cale CM, Pierce CM, Wilson LC, Hennekam RC (2007). "Immunological abnormalities in CHARGE syndrome". European Journal of Medical Genetics. 50 (5): 338–345. doi:10.1016/j.ejmg.2007.05.002. PMID17684005.
Lalani SR, Hefner MA, Belmont JW, Davenport SL (2012-02-02). "CHD7 Disorder". CHARGE Syndrome. University of Washington, Seattle. PMID20301296. NBK1117. In GeneReviews
Bardakjian T, Weiss A, Schneider AS (2006-05-26). "Microphthalmia/Anophthalmia/Coloboma Spectrum – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY". Anophthalmia/Microphthalmia Overview. University of Washington, Seattle. PMID20301552. NBK1378. In GeneReviews
2ckc: SOLUTION STRUCTURES OF THE BRK DOMAINS OF THE HUMAN CHROMO HELICASE DOMAIN 7 AND 8, REVEALS STRUCTURAL SIMILARITY WITH GYF DOMAIN SUGGESTING A ROLE IN PROTEIN INTERACTION
